Clinical Trial Update: Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating haloperidol prophylaxis to prevent delirium in patients undergoing cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: McMaster University | Conditions: Postoperative Confusion | Phase 3 | Status: COMPLETED